Inhaled NO for preterm infants: no benefit, high cost

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.480, 2005-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful resource allocation for high-cost, high-benefit treatment

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 337, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients

By Griffin A.D.

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 293-301

Adis International

Access to resources Recommend Favorite

Fungal Chemoprophylaxis with Fluconazole in Preterm Infants

By Sesmero José Sedano Francisco García Teresa Brussi Marta Ferrández Javier Fernández Raúl Díez Guillén Cristóbal

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 475-477

Springer Publishing Company

Access to resources Recommend Favorite

Debating RSV prophylaxis in preterm infants

Inpharma, Vol. 1, Iss. 1266, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Debating RSV prophylaxis in preterm infants

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 291, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite